Glenmark’s bi-apecific antibody – GBR 1302 to enter Phase I trials
Glenmark expects to obtain approval for the initiation of clinical studies with GBR1302 during this financial year
Glenmark…
Author
Study: Tresiba U200 delivers significantly lower rates of confirmed hypoglycaemia vs insulin…
More concentrated formulation means fewer injections, and consequently better patient compliance
New data presented at the 51st…
Industry titans Biocon, PBOA, PCI Clinical Services and Pharmatech Associates join CPhI annual…
Dr Fiona Withey, Managing Director UK PCI Clinical Services, first ever female executive to join the expert panel
CPhI Worldwide,…
‘It is the most comprehensive healthcare and lifesciences management programme in India’
Dr (Prof) Ajit Parulekar, Dean—Healthcare Management, Goa Institute of Management talks about their newly introduced PGDM course…